Skip to main content
Michael Scheiber, MD, Obstetrics & Gynecology, Cincinnati, OH

Michael David Scheiber MD MPH, FACOG

Reproductive Endocrinology & Infertility


Director of Reproductive Research, Institute for Reproductive Health Volunteer Associate Professor of Medicine, University of Cincinnati College of Medicine

Join to View Full Profile
  • 3805 Edwards RdSuite 450Cincinnati, OH 45209

  • Phone+1 513-924-5550

  • Fax+1 513-924-5551

Dr. Scheiber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineFellowship, Reproductive Endocrinology and Infertility, 1996 - 1999
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Obstetrics and Gynecology, 1990 - 1994
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2027
  • KY State Medical License
    KY State Medical License 2006 - 2026
  • OH State Medical License
    OH State Medical License 1996 - 2026
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Reproductive Endocrinology/Infertility
    American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Top MD Consumers Checkbook
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Ferring Pharmaceuticals Presents Two New Analyses of Pivotal Trial Data for Follitropin Delta (FE 999049) at ASRM 2025
    Ferring Pharmaceuticals Presents Two New Analyses of Pivotal Trial Data for Follitropin Delta (FE 999049) at ASRM 2025October 27th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: